Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim West

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Science Translational Medicine|April 21, 2017
Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathyKiran Yanamandra, Tirth K Patel, Hong Jiang, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 27, 2023
Plasma Aβ42/40 and cognitive variability are associated with cognitive function in Black Americans: Findings from the AA-FAIM cohortBarbara Fischer, Carol Ann Van Hulle, Rebecca Langhough, et al.
Neurology|April 22, 2022
Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament LightSuzanne E Schindler, Thomas K Karikari, Nicholas J Ashton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2024
Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and Aβ42/40 ratio to identify presence of brain amyloidMatthew R Meyer, Kristopher M Kirmess, Stephanie Eastwood, et al.
Brain : a Journal of Neurology|February 25, 2026
Modelling the temporal evolution of plasma p-tau217, amyloid PET, tau PET and cognitionPetrice M Cogswell, Emily S Lundt, Terry M Therneau, et al.
JAMA Network Open|April 21, 2022
Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive ImpairmentYan Hu, Kristopher M Kirmess, Matthew R Meyer, et al.
Archives of Sexual Behavior|October 1, 2016
The Diversity and Prevalence of Sexual Orientation Self-Labels in a New Zealand National SampleLara M Greaves, Fiona Kate Barlow, Carol H J Lee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 30, 2025
Association of plasma Alzheimer's disease biomarkers with cognitive decline in cognitively unimpaired individualsPetrice M Cogswell, Heather J Wiste, Terry M Therneau, et al.
Nature Medicine|December 20, 2011
Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targetsMali Jiang, Jiawei Wang, Jinrong Fu, et al.
JAMA Neurology|February 2, 2026
Plasma Phosphorylated Tau 217 Cutoffs for Amyloid Pathology and Kidney Function, Body Mass Index, and AnemiaJihwan Yun, Jungah Lee, Daeun Shin, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Science Translational Medicine|April 21, 2017
Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathyKiran Yanamandra, Tirth K Patel, Hong Jiang, et al.
Alzheimer'S & Dementia (New York, N. Y.)|September 27, 2023
Plasma Aβ42/40 and cognitive variability are associated with cognitive function in Black Americans: Findings from the AA-FAIM cohortBarbara Fischer, Carol Ann Van Hulle, Rebecca Langhough, et al.
Neurology|April 22, 2022
Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament LightSuzanne E Schindler, Thomas K Karikari, Nicholas J Ashton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 16, 2024
Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and Aβ42/40 ratio to identify presence of brain amyloidMatthew R Meyer, Kristopher M Kirmess, Stephanie Eastwood, et al.
Brain : a Journal of Neurology|February 25, 2026
Modelling the temporal evolution of plasma p-tau217, amyloid PET, tau PET and cognitionPetrice M Cogswell, Emily S Lundt, Terry M Therneau, et al.
JAMA Network Open|April 21, 2022
Assessment of a Plasma Amyloid Probability Score to Estimate Amyloid Positron Emission Tomography Findings Among Adults With Cognitive ImpairmentYan Hu, Kristopher M Kirmess, Matthew R Meyer, et al.
Archives of Sexual Behavior|October 1, 2016
The Diversity and Prevalence of Sexual Orientation Self-Labels in a New Zealand National SampleLara M Greaves, Fiona Kate Barlow, Carol H J Lee, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 30, 2025
Association of plasma Alzheimer's disease biomarkers with cognitive decline in cognitively unimpaired individualsPetrice M Cogswell, Heather J Wiste, Terry M Therneau, et al.
Nature Medicine|December 20, 2011
Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targetsMali Jiang, Jiawei Wang, Jinrong Fu, et al.
JAMA Neurology|February 2, 2026
Plasma Phosphorylated Tau 217 Cutoffs for Amyloid Pathology and Kidney Function, Body Mass Index, and AnemiaJihwan Yun, Jungah Lee, Daeun Shin, et al.
Pageof 5